Rovalpituzumab tesirine | Interleukin Related interleukin-related.com

Product Name :
Rovalpituzumab tesirine

Search keywords :
Rovalpituzumab

drugId :
null

Target Vo:
Delta-like protein 3

Target Vo Short Name :
DLL3

Moa_Name:
DNA damage stimulants

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Abbvie Inc

Active Company_Name :

Active Indication_Name:

In Active Indication_Name:
Melanoma

Termination Status :
Phase 3 Clinical

China Termination Status :
Phase 3 Clinical

Highest Status:
Discontinued

China Highest Status:
Discontinued

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Integrin alpha 5 Rabbit mAb web
HER2 Rabbit mAb MedChemExpress
Calpastatin Antibody: Calpastatin Antibody is a non-conjugated and Mouse origined monoclonal antibody about 120 kDa, targeting to Calpastatin. It can be used for WB,ICC,IHC-P assays with tag free, in the background of Human.

Author: Interleukin Related

Related Posts